Holdings
Sector Gamma As
As of Jun 30, 2026, Sector Gamma As reported 37 positions worth US$416M. Largest: Bristol-myers Squibb Company, Merck & Company, Inc. and Pfizer, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Bristol-myers Squibb Company | 726K | US$41.8M | −102K | Jun 30, 2026 |
| Merck & Company, Inc. | 217K | US$27.9M | −43,332 | Jun 30, 2026 |
| Pfizer, Inc. | 1M | US$24.2M | −87,170 | Jun 30, 2026 |
| Incyte Corporation | 171K | US$19.4M | −29,757 | Jun 30, 2026 |
| Elevance Health, Inc. | 44,499 | US$17.2M | +537 | Jun 30, 2026 |
| Biomarin Pharmaceutical Inc. | 295K | US$16.9M | +55,000 | Jun 30, 2026 |
| Thermo Fisher Scientific Inc | 33,584 | US$16.8M | new | Jun 30, 2026 |
| Cvs Health Corporation | 155K | US$16.1M | +20,000 | Jun 30, 2026 |
| Iqvia Holdings, Inc. | 77,944 | US$15.1M | +37,714 | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 189K | US$15M | +20,000 | Jun 30, 2026 |